Corteva, Inc. (NYSE:CTVA) Shares Acquired by Capital Advisors Ltd. LLC

Capital Advisors Ltd. LLC raised its position in shares of Corteva, Inc. (NYSE:CTVA) by 44.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 566 shares of the company’s stock after buying an additional 174 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in Corteva were worth $33,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. Pinnacle Bancorp Inc. grew its position in shares of Corteva by 26.1% during the 3rd quarter. Pinnacle Bancorp Inc. now owns 962 shares of the company’s stock valued at $57,000 after buying an additional 199 shares during the last quarter. Herr Investment Group LLC raised its position in shares of Corteva by 2.8% during the 1st quarter. Herr Investment Group LLC now owns 7,400 shares of the company’s stock worth $427,000 after purchasing an additional 200 shares during the period. Azzad Asset Management Inc. ADV boosted its position in Corteva by 0.4% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 48,200 shares of the company’s stock valued at $2,600,000 after purchasing an additional 203 shares during the period. Westhampton Capital LLC grew its stake in Corteva by 2.5% during the 3rd quarter. Westhampton Capital LLC now owns 8,641 shares of the company’s stock worth $508,000 after buying an additional 213 shares during the last quarter. Finally, Albion Financial Group UT increased its position in Corteva by 77.2% in the first quarter. Albion Financial Group UT now owns 505 shares of the company’s stock worth $29,000 after buying an additional 220 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Corteva stock opened at $60.35 on Monday. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $61.21. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.72 and a quick ratio of 1.17. The company has a market cap of $42.06 billion, a P/E ratio of 76.39, a price-to-earnings-growth ratio of 1.66 and a beta of 0.77. The firm’s 50 day simple moving average is $57.13 and its 200-day simple moving average is $55.16.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.09. The business had revenue of $6.11 billion for the quarter, compared to the consensus estimate of $6.15 billion. Corteva had a return on equity of 7.30% and a net margin of 5.31%. Corteva’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.60 earnings per share. As a group, equities research analysts predict that Corteva, Inc. will post 2.66 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. JPMorgan Chase & Co. cut their target price on Corteva from $57.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Citigroup began coverage on shares of Corteva in a research report on Wednesday, October 23rd. They issued a “buy” rating and a $68.00 target price for the company. Argus lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Wells Fargo & Company reduced their price objective on Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a research report on Friday, August 2nd. Finally, KeyCorp lowered their target price on Corteva from $66.00 to $62.00 and set an “overweight” rating on the stock in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $62.84.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.